Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation 
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated 
Asian Stocks Gain Amid Iran Conflict Uncertainty 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Why have so few atrocities ever been recognised as genocide? 
How to support someone who is grieving: five research-backed strategies 
U.S. Oil Prices Slide as Middle East Ceasefire Talks Spark Market Optimism 
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict 
Iran-Israel Missile Strikes Continue Amid Mixed Signals on U.S.-Iran Diplomacy 
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update 
Berkshire Hathaway and Tokio Marine Form Major Strategic Insurance Partnership 
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets 
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds 
Bank of Japan Eyes April Rate Hike Despite Inflation Dip, ING Says 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
